Schwab Charles CORP Form 4 insider transactions

Director Frank C Herringer acquired 2,244 nonqualified stock options of Schwab Charles Corp on July 1, 2024, in lieu of cash compensation.

Jonathan S. Beatty, MD, Head of Advisor Services at Charles Schwab Corp, reports the acquisition of 11,191 shares of common stock through a restricted stock unit grant.

Director Carolyn Schwab-Pomerantz sold shares of Schwab (SCHW) on June 20, 2024, under a pre-arranged 10b5-1 trading plan.

Bernard J. Clark, MD Head of Advisor Services at Charles Schwab Corp, exercised stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Director John K. Adams Jr. reported the acquisition of common stock and nonqualified stock options in Charles Schwab Corp.

Charles A. Ruffel, a director at Charles Schwab Corp, reported the acquisition of restricted stock units and a nonqualified stock option, along with dividend reinvestments.

Director Todd M. Ricketts reports the acquisition of restricted stock units and nonqualified stock options in Charles Schwab Corporation under the company's 2022 Stock Incentive Plan.

Bernard J. Clark, MD Head of Advisor Services at Charles Schwab Corp, exercised stock options and sold shares on May 28, 2024, according to a recent SEC filing.

Director Gerri Martin-Flickinger received stock and option grants from Charles Schwab on May 28, 2024, according to a recent SEC filing.

Director Paula A. Sneed reports acquisition of restricted stock units and stock options in Charles Schwab Corp.

Carolyn Schwab-Pomerantz, a director of Charles Schwab Corp, reported the acquisition of restricted stock units and stock options in a recent SEC filing.

Director Arun Sarin reports the acquisition of restricted stock units and stock options in Charles Schwab Corp.

Director Bharat Masrani reports the acquisition of restricted stock units and nonqualified stock options in Schwab.

Director Brian M. Levitt reported the acquisition of common stock and nonqualified stock options in Charles Schwab Corp on May 28, 2024.

Director Frank Herringer reports receiving stock and option grants from Schwab on May 28, 2024.

Director Stephen Ellis reports the acquisition of restricted stock units and stock options in Charles Schwab Corporation.

Christopher V. Dodds, a director at Charles Schwab Corp, received stock and option grants under the company's 2022 Stock Incentive Plan.

Director Joan Dea receives stock and option grants under Charles Schwab's 2022 Stock Incentive Plan.

Marianne C. Brown, a director at Charles Schwab Corp, was granted stock options and restricted stock units under the company's 2022 Stock Incentive Plan.

Director Bharat Masrani reports a transaction involving Schwab common stock on May 22, 2024.

Director Brian M Levitt reports disposition of Schwab shares to cover tax obligations related to settled restricted stock units.

Director Carolyn Schwab-Pomerantz sold shares of Schwab (SCHW) on May 20, 2024, under a pre-arranged 10b5-1 trading plan.

Charles R. Schwab, Co-Chairman of Charles Schwab Corp, reports a transfer of 64,100 shares of common stock to a trust.

Bharat Masrani, a director at Charles Schwab Corp, reported disposing of common stock to cover tax obligations related to settled restricted stock units.

Brian M. Levitt, a director at Charles Schwab Corp, reported disposing of common stock to cover tax obligations related to settled restricted stock units.

Charles Schwab, Co-Chairman of Charles Schwab Corp, recently sold shares of the company's common stock in multiple transactions.

Carolyn Schwab-Pomerantz, a director at Charles Schwab Corp, amended a previous Form 4 filing to include 6,353 directly held shares that were initially omitted due to an administrative error.

Carolyn Schwab-Pomerantz, a director at Charles Schwab Corp, sold 26,315 shares of common stock at an average price of $76.1326 on May 9, 2024.

Charles Schwab, Co-Chairman of Charles Schwab Corp, reports changes in his beneficial ownership of SCHW stock due to gifts.

Carolyn Schwab-Pomerantz, a director at Charles Schwab Corp, sold 13,113 shares of common stock for $76.3849 per share on May 6, 2024.